Showing 1391-1400 of 1626 results for "".
- The Number of Optometric Practices Offering neurolens Contoured Prism Lenses More Than Quadrupled in 2018https://modernod.com/news/the-number-of-optometric-practices-offering-neurolens-contoured-prism-lenses-more-than-quadrupled-in-2018/2479617/Costa Mesa, California-based neurolens announced that adoption of their prescription lenses has grown among US optometric (OD) practices and by year end, 31 states will carry the company’s neurolenses and the neurolens measurement device. neurolenses are the first and only prescripti
- Prospective Study for NaturalVue Multifocal Demonstrates Decreased Refractive Error Change in Fast-Progressing Myopic Childrenhttps://modernod.com/news/prospective-study-for-naturalvue-multifocal-demonstrates-decreased-refractive-error-change-in-fast-progressing-myopic-children/2479681/Thomas Aller, OD, presented updated findings from a prospective clinical trial of NaturalVue (etafilcon A) 1 Day Multifocal Contact Lenses at a briefing for media and industry leaders at the American Academy of Optometry (AAO) Conference in San Antonio on November 9. The NaturalVue portfolio of p
- Non-Contact Panretinal Photocoagulation for Navilas 577s Introduced at AAO 2018https://modernod.com/news/non-contact-panretinal-photocoagulation-for-navilas-577s-introduced-at-aao-2018/2479753/At the AAO 2018 meeting in Chicago, OD-OS is launching a new widefield objective which brings non-contact panretinal photocoagulation with access to the far periphery (ora serrata) to the Navilas 577s Laser System. The new option for peripheral treatments can further enhance compliance of sensiti
- Trump to Nominate Stephen Hahn, Cancer Researcher, to Head FDAhttps://modernod.com/news/trump-to-nominate-stephen-hahn-cancer-researcher-to-head-fda/2477068/President Trump said Friday that he intended to nominate Stephen M. Hahn, MD, a top executive at The University of Texas M.D. Anderson Cancer Center, to be the next commissioner of the Food and Drug Administration, according to a
- AOA: Changes on the Horizon for Evaluation and Management Serviceshttps://modernod.com/news/aoa-changes-on-the-horizon-for-evaluation-and-management-services/2477202/There has been a lot of information disseminated by various individuals and organizations regarding upcoming changes to coding and reimbursement for evaluation and management services (E/M services). Given the importance of E/M services in patient care, it’s critical that all doctors of opt
- ProQR Receives Orphan Drug Designation from FDA for QR-1123 for Autosomal Dominant Retinitis Pigmentosahttps://modernod.com/news/proqr-receives-orphan-drug-designation-from-fda-for-qr-1123-for-autosomal-dominant-retinitis-pigmentosa/2477112/ProQR Therapeutics announced that it received orphan drug designation (ODD) from the FDA for QR-1123, a first-in-class investigational antisense oligonucleotide designed to address the underlying cause of vision loss associated with autosomal dominant retinitis pigmentosa (adRP) due to the P23H m
- Oculis Appoints New Members of Senior Management Teamhttps://modernod.com/news/oculis-appoints-new-members-of-senior-management-team/2479655/Oculis announced the appointments of Fabio Baschiera, PharmD, MPh, PhD, as Vice President of Clinical Development, and Louie-Anne Gauthier, M.Sc., as Vice President of Strategic Marketing, Business Development and Licensing. “We are delighted to welcome Fabio and Louie-Anne to the Oculis m
- SECO International Names Dr. R. Max Raynor as 2021 Presidenthttps://modernod.com/news/seco-international-names-dr-r-max-raynor-as-2021-president/2477497/SECO International has named R. Max Raynor, OD, as the next president. His term began on March 7, 2020, and will last through February 28, 2021. Dr. Raynor officially accepted the honor during the House of Delegates meeting held on Saturday, March 7 at SECO 20/20. “Dr. Raynor has dedicated
- The Vision Council Opens Registration for 2026 Lab Leadership Forum in Las Vegashttps://modernod.com/news/the-vision-council-opens-registration-for-2026-lab-leadership-forum-in-las-vegas/2487132/The Vision Council has opened registration for the 2026 Lab Leadership Forum, the organization’s flagship event for optical lab professionals, scheduled for Sept. 16-18, 2026, at the M Resort Spa Casino in Las Vegas. The annual
- Clearside Biomedical Expands Patent Portfolio in the US and Europehttps://modernod.com/news/clearside-biomedical-expands-patent-portfolio-in-the-us-and-europe/2478203/Clearside Biomedical announced the recent issuance of three additional patents in the United States and Europe. The United States Patent and Trademark Office (USPTO) recently granted patent number 10,722,396 to Clearside. This patent covers Clearside’s SCS M